Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Jones

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Chinese Medical Journal Pulmonary and Critical Care Medicine|April 1, 2024
Dysregulated bidirectional epithelial-mesenchymal crosstalk: a core determinant of lung fibrosis progressionLiudi Yao, Zijian Xu, Donna E Davies, et al.
Journal of Biomedical Optics|June 19, 2021
Examining lysyl oxidase-like modulation of collagen architecture in 3D spheroid models of idiopathic pulmonary fibrosis via second-harmonic generation microscopyDarian S James, Christopher J Brereton, Donna E Davies, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 5, 2005
Urinary and plasma organic acids and amino acids in chronic fatigue syndromeMark G Jones, Elizabeth Cooper, Saira Amjad, et al.
Expert Opinion on Drug Safety|August 18, 2016
The safety of new drug treatments for idiopathic pulmonary fibrosisSophie Fletcher, Mark G Jones, Katherine Spinks, et al.
International Journal of Molecular Sciences|February 23, 2020
Deconvolution of RNA-Seq Analysis of Hyperbaric Oxygen-Treated Mice Lungs Reveals Mesenchymal Cell Subtype ChangesYuan Yuan, Yilu Zhou, Yali Li, et al.
Pharmacology & Therapeutics|December 28, 2020
Idiopathic pulmonary fibrosis: Disease mechanisms and drug developmentPaolo Spagnolo, Jonathan A Kropski, Mark G Jones, et al.
Respirology (Carlton, Vic.)|May 12, 2020
Opportunities to diagnose fibrotic lung diseases in routine care: A primary care cohort studyMark G Jones, Christopher R T Hillyar, Anjan Nibber, et al.
Frontiers in Molecular Biosciences|April 19, 2021
Quantitative Proteomic Analysis in Alveolar Type II Cells Reveals the Different Capacities of RAS and TGF-β to Induce Epithelial-Mesenchymal TransitionYilu Zhou, Charlotte Hill, Liudi Yao, et al.
ERJ Open Research|July 13, 2026
Beneficial effects of the AT<sub>2</sub> receptor agonist buloxibutid (C21) against acute alveolar epithelial cell inflammation during antiviral responsesFranco Conforti, Joseph Bell, Robert Ridley, et al.
Respirology (Carlton, Vic.)|November 2, 2011
A disintegrin and metalloprotease (ADAM) 33 protein in patients with pulmonary sarcoidosisAsif Shaffiq, Hans Michael Haitchi, Yun Yung Pang, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Chinese Medical Journal Pulmonary and Critical Care Medicine|April 1, 2024
Dysregulated bidirectional epithelial-mesenchymal crosstalk: a core determinant of lung fibrosis progressionLiudi Yao, Zijian Xu, Donna E Davies, et al.
Journal of Biomedical Optics|June 19, 2021
Examining lysyl oxidase-like modulation of collagen architecture in 3D spheroid models of idiopathic pulmonary fibrosis via second-harmonic generation microscopyDarian S James, Christopher J Brereton, Donna E Davies, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 5, 2005
Urinary and plasma organic acids and amino acids in chronic fatigue syndromeMark G Jones, Elizabeth Cooper, Saira Amjad, et al.
Expert Opinion on Drug Safety|August 18, 2016
The safety of new drug treatments for idiopathic pulmonary fibrosisSophie Fletcher, Mark G Jones, Katherine Spinks, et al.
International Journal of Molecular Sciences|February 23, 2020
Deconvolution of RNA-Seq Analysis of Hyperbaric Oxygen-Treated Mice Lungs Reveals Mesenchymal Cell Subtype ChangesYuan Yuan, Yilu Zhou, Yali Li, et al.
Pharmacology & Therapeutics|December 28, 2020
Idiopathic pulmonary fibrosis: Disease mechanisms and drug developmentPaolo Spagnolo, Jonathan A Kropski, Mark G Jones, et al.
Respirology (Carlton, Vic.)|May 12, 2020
Opportunities to diagnose fibrotic lung diseases in routine care: A primary care cohort studyMark G Jones, Christopher R T Hillyar, Anjan Nibber, et al.
Frontiers in Molecular Biosciences|April 19, 2021
Quantitative Proteomic Analysis in Alveolar Type II Cells Reveals the Different Capacities of RAS and TGF-β to Induce Epithelial-Mesenchymal TransitionYilu Zhou, Charlotte Hill, Liudi Yao, et al.
ERJ Open Research|July 13, 2026
Beneficial effects of the AT<sub>2</sub> receptor agonist buloxibutid (C21) against acute alveolar epithelial cell inflammation during antiviral responsesFranco Conforti, Joseph Bell, Robert Ridley, et al.
Respirology (Carlton, Vic.)|November 2, 2011
A disintegrin and metalloprotease (ADAM) 33 protein in patients with pulmonary sarcoidosisAsif Shaffiq, Hans Michael Haitchi, Yun Yung Pang, et al.
Pageof 6